Echinacea
•Last Updated: September 28 2022
Echinacea purpurea is an herb commonly used either in response to or daily for prevention of the common cold. It outperforms placebo unreliably and the amount of benefit derived is similarly unreliable.
Echinacea is most often used for
Last Updated: September 28 2022
The term "echinacea" refers to a genera of plants, and a few species in this family including purpurea and angustifolia are desired due to their alkylamide content (seen as the active ingredients). It's often taken as a tincture, but dry capsules are also common.
Overall, echinacea appears to be somewhat effective for fighting off upper respiratory tract infections (mostly studied for the common cold), and when taken consistently as a prophylactic, it has support from research. It has also been studied for its potential ability to accelerate the rate of recovery in sickness, but the current evidence for that highly ambiguous. There are trials suggesting remarkable recovery rates, and there are trials suggesting no benefits whatsoever. Overall, it doesn't look very potent. Limited research suggests that it can increase the levels of a variety of immune cells, but more research is needed to be confident in this.
Echinacea hasn't demonstrated notably, greater adverse events in trials than placebo, however, as with herbal extracts in general, there may be a risk for drug interactions, particularly for those who take multiple medications.
Note that Echinacea is also known as:
- Brauneria purpurea
- Echinacea intermedia
- Rudbeckia purpurea
- Purple coneflower herb
- Coneflower
- Red sunflower
For dehydrated powders (including encapsulated echinacea) the species of purpuera tends to be used and oral doses are taken upwards of 300mg thrice a day (900mg daily) and 500mg thrice daily (1,500mg daily).
Tinctures of an ethanolic extract of the aerial parts (leaves and stems) appears to be used in the concentration of 2.5mL thrice a day or up to 10mL daily.
There is no much evidence as to whether these are the optimal doses, and studies seem to be very hetereogeneous in their benefits due to lack of standardization.
What works and what doesn't?
Unlock the full potential of Examine
Latest ResearchRead all studies
1.^Hermann R, von Richter OClinical evidence of herbal drugs as perpetrators of pharmacokinetic drug interactionsPlanta Med.(2012 Sep)
2.^Wu L, Rowe EW, Jeftinija K, Jeftinija S, Rizshsky L, Nikolau BJ, McKay J, Kohut M, Wurtele ESEchinacea-induced cytosolic Ca2+ elevation in HEK293BMC Complement Altern Med.(2010 Nov 23)
3.^Dalby-Brown L, Barsett H, Landbo AK, Meyer AS, Mølgaard PSynergistic antioxidative effects of alkamides, caffeic acid derivatives, and polysaccharide fractions from Echinacea purpurea on in vitro oxidation of human low-density lipoproteinsJ Agric Food Chem.(2005 Nov 30)
5.^Ma H, Carpenter CL, Sullivan-Halley J, Bernstein LThe roles of herbal remedies in survival and quality of life among long-term breast cancer survivors--results of a prospective studyBMC Cancer.(2011 Jun 6)
6.^Bright-Gbebry M, Makambi KH, Rohan JP, Llanos AA, Rosenberg L, Palmer JR, Adams-Campbell LLUse of multivitamins, folic acid and herbal supplements among breast cancer survivors: the black women's health studyBMC Complement Altern Med.(2011 Apr 15)
7.^Engdal S, Klepp O, Nilsen OGIdentification and exploration of herb-drug combinations used by cancer patientsIntegr Cancer Ther.(2009 Mar)
8.^Walsh NP, Gleeson M, Pyne DB, Nieman DC, Dhabhar FS, Shephard RJ, Oliver SJ, Bermon S, Kajeniene APosition statement. Part two: Maintaining immune healthExerc Immunol Rev.(2011)
9.^Senchina DS, Shah NB, Doty DM, Sanderson CR, Hallam JEHerbal supplements and athlete immune function--what's proven, disproven, and unprovenExerc Immunol Rev.(2009)
10.^Ritchie MR, Gertsch J, Klein P, Schoop REffects of Echinaforce® treatment on ex vivo-stimulated blood cellsPhytomedicine.(2011 Jul 15)
11.^Thomsen MO, Fretté XC, Christensen KB, Christensen LP, Grevsen KSeasonal variations in the concentrations of lipophilic compounds and phenolic acids in the roots of Echinacea purpurea and Echinacea pallidaJ Agric Food Chem.(2012 Dec 12)
12.^Hohmann J, Rédei D, Forgo P, Szabó P, Freund TF, Haller J, Bojnik E, Benyhe SAlkamides and a neolignan from Echinacea purpurea roots and the interaction of alkamides with G-protein-coupled cannabinoid receptorsPhytochemistry.(2011 Oct)
14.^Spelman K, Wetschler MH, Cech NBComparison of alkylamide yield in ethanolic extracts prepared from fresh versus dry Echinacea purpurea utilizing HPLC-ESI-MSJ Pharm Biomed Anal.(2009 Jul 12)
17.^Chen Y, Fu T, Tao T, Yang J, Chang Y, Wang M, Kim L, Qu L, Cassady J, Scalzo R, Wang XMacrophage activating effects of new alkamides from the roots of Echinacea speciesJ Nat Prod.(2005 May)
18.^Lu Y, Li J, Li M, Hu X, Tan J, Liu ZHEfficient counter-current chromatographic isolation and structural identification of two new cinnamic acids from Echinacea purpureaNat Prod Commun.(2012 Oct)
19.^Benson JM, Pokorny AJ, Rhule A, Wenner CA, Kandhi V, Cech NB, Shepherd DMEchinacea purpurea extracts modulate murine dendritic cell fate and functionFood Chem Toxicol.(2010 May)
20.^Liu Y, Zhang S, Zhang F, Hu RAdjuvant activity of Chinese herbal polysaccharides in inactivated veterinary rabies vaccinesInt J Biol Macromol.(2012 Apr 1)
21.^Di Pierro F, Rapacioli G, Ferrara T, Togni SUse of a standardized extract from Echinacea angustifolia (Polinacea) for the prevention of respiratory tract infectionsAltern Med Rev.(2012 Mar)
22.^Ragupathi G, Yeung KS, Leung PC, Lee M, Lau CB, Vickers A, Hood C, Deng G, Cheung NK, Cassileth B, Livingston PEvaluation of widely consumed botanicals as immunological adjuvantsVaccine.(2008 Sep 2)
24.^Chicca A, Pellati F, Adinolfi B, Matthias A, Massarelli I, Benvenuti S, Martinotti E, Bianucci AM, Bone K, Lehmann R, Nieri PCytotoxic activity of polyacetylenes and polyenes isolated from roots of Echinacea pallidaBr J Pharmacol.(2008 Mar)
25.^Binns SE, Livesey JF, Arnason JT, Baum BRPhytochemical variation in echinacea from roots and flowerheads of wild and cultivated populationsJ Agric Food Chem.(2002 Jun 19)
26.^Rininger JA, Kickner S, Chigurupati P, McLean A, Franck ZImmunopharmacological activity of Echinacea preparations following simulated digestion on murine macrophages and human peripheral blood mononuclear cellsJ Leukoc Biol.(2000 Oct)
27.^Pugh ND, Tamta H, Balachandran P, Wu X, Howell J, Dayan FE, Pasco DSThe majority of in vitro macrophage activation exhibited by extracts of some immune enhancing botanicals is due to bacterial lipoproteins and lipopolysaccharidesInt Immunopharmacol.(2008 Jul)
28.^Pugh ND, Jackson CR, Pasco DSTotal bacterial load within Echinacea purpurea, determined using a new PCR-based quantification method, is correlated with LPS levels and in vitro macrophage activityPlanta Med.(2013 Jan)
29.^Brinkeborn RM, Shah DV, Degenring FHEchinaforce and other Echinacea fresh plant preparations in the treatment of the common cold. A randomized, placebo controlled, double-blind clinical trialPhytomedicine.(1999 Mar)
30.^Kim HO, Durance TD, Scaman CH, Kitts DDRetention of alkamides in dried Echinacea purpureaJ Agric Food Chem.(2000 Sep)
31.^Kim HO, Durance TD, Scaman CH, Kitts DDRetention of caffeic acid derivatives in dried Echinacea purpureaJ Agric Food Chem.(2000 Sep)
32.^Stuart DL, Wills RBEffect of drying temperature on alkylamide and cichoric acid concentrations of Echinacea purpureaJ Agric Food Chem.(2003 Mar 12)
33.^Livesey J, Awang DV, Arnason JT, Letchamo W, Barrett M, Pennyroyal GEffect of temperature on stability of marker constituents in Echinacea purpurea root formulationsPhytomedicine.(1999 Nov)
36.^Chen XM, Hu C, Raghubeer E, Kitts DDEffect of high pressure pasteurization on bacterial load and bioactivity of Echinacea purpureaJ Food Sci.(2010 Sep)
38.^Schapowal AEfficacy and safety of Echinaforce® in respiratory tract infectionsWien Med Wochenschr.(2013 Feb)
39.^Woelkart K, Marth E, Suter A, Schoop R, Raggam RB, Koidl C, Kleinhappl B, Bauer RBioavailability and pharmacokinetics of Echinacea purpurea preparations and their interaction with the immune systemInt J Clin Pharmacol Ther.(2006 Sep)
40.^Gertsch J, Schoop R, Kuenzle U, Suter AEchinacea alkylamides modulate TNF-alpha gene expression via cannabinoid receptor CB2 and multiple signal transduction pathwaysFEBS Lett.(2004 Nov 19)
41.^Shah SA, Sander S, White CM, Rinaldi M, Coleman CIEvaluation of echinacea for the prevention and treatment of the common cold: a meta-analysisLancet Infect Dis.(2007 Jul)
42.^Matthias A, Blanchfield JT, Penman KG, Toth I, Lang CS, De Voss JJ, Lehmann RPPermeability studies of alkylamides and caffeic acid conjugates from echinacea using a Caco-2 cell monolayer modelJ Clin Pharm Ther.(2004 Feb)
43.^Jager H, Meinel L, Dietz B, Lapke C, Bauer R, Merkle HP, Heilmann JTransport of alkamides from Echinacea species through Caco-2 monolayersPlanta Med.(2002 May)
44.^Matthias A, Penman KG, Matovic NJ, Bone KM, De Voss JJ, Lehmann RPBioavailability of Echinacea constituents: Caco-2 monolayers and pharmacokinetics of the alkylamides and caffeic acid conjugatesMolecules.(2005 Oct 30)
45.^Matthias A, Gillam EM, Penman KG, Matovic NJ, Bone KM, De Voss JJ, Lehmann RPCytochrome P450 enzyme-mediated degradation of Echinacea alkylamides in human liver microsomesChem Biol Interact.(2005 Jun 30)
46.^Woelkart K, Koidl C, Grisold A, Gangemi JD, Turner RB, Marth E, Bauer RBioavailability and pharmacokinetics of alkamides from the roots of Echinacea angustifolia in humansJ Clin Pharmacol.(2005 Jun)
47.^Matthias A, Addison RS, Penman KG, Dickinson RG, Bone KM, Lehmann RPEchinacea alkamide disposition and pharmacokinetics in humans after tablet ingestionLife Sci.(2005 Sep 2)
48.^Goey AK, Rosing H, Meijerman I, Sparidans RW, Schellens JH, Beijnen JHThe bioanalysis of the major Echinacea purpurea constituents dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides in human plasma using LC-MS/MSJ Chromatogr B Analyt Technol Biomed Life Sci.(2012 Aug 1)
49.^Gorski JC, Huang SM, Pinto A, Hamman MA, Hilligoss JK, Zaheer NA, Desai M, Miller M, Hall SDThe effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivoClin Pharmacol Ther.(2004 Jan)
50.^Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Carrier J, Khan IA, Edwards DJ, Shah AIn vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmettoClin Pharmacol Ther.(2004 Nov)
51.^Gurley BJ, Swain A, Hubbard MA, Williams DK, Barone G, Hartsfield F, Tong Y, Carrier DJ, Cheboyina S, Battu SKClinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and EchinaceaMol Nutr Food Res.(2008 Jul)
52.^Moltó J, Valle M, Miranda C, Cedeño S, Negredo E, Barbanoj MJ, Clotet BHerb-drug interaction between Echinacea purpurea and darunavir-ritonavir in HIV-infected patientsAntimicrob Agents Chemother.(2011 Jan)
53.^Penzak SR, Robertson SM, Hunt JD, Chairez C, Malati CY, Alfaro RM, Stevenson JM, Kovacs JAEchinacea purpurea significantly induces cytochrome P450 3A activity but does not alter lopinavir-ritonavir exposure in healthy subjectsPharmacotherapy.(2010 Aug)
54.^Abdul MI, Jiang X, Williams KM, Day RO, Roufogalis BD, Liauw WS, Xu H, Matthias A, Lehmann RP, McLachlan AJPharmacokinetic and pharmacodynamic interactions of echinacea and policosanol with warfarin in healthy subjectsBr J Clin Pharmacol.(2010 May)
55.^Wittkowsky AKWarfarin and other coumarin derivatives: pharmacokinetics, pharmacodynamics, and drug interactionsSemin Vasc Med.(2003 Aug)
56.^Mahringer A, Ardjomand-Woelkart K, Bauer R, Fricker G, Efferth TAlkamides from Echinacea angustifolia Interact with P-Glycoprotein of Primary Brain Capillary Endothelial Cells Isolated from Porcine Brain Blood VesselsPlanta Med.(2013 Mar)
57.^Qiang Z, Hauck C, McCoy JA, Widrlechner MP, Reddy MB, Murphy PA, Hendrich SEchinacea sanguinea and Echinacea pallida Extracts Stimulate Glucuronidation and Basolateral Transfer of Bauer Alkamides 8 and 10 and Ketone 24 and Inhibit P-glycoprotein Transporter in Caco-2 CellsPlanta Med.(2013 Mar)
58.^Woelkart K, Xu W, Pei Y, Makriyannis A, Picone RP, Bauer RThe endocannabinoid system as a target for alkamides from Echinacea angustifolia rootsPlanta Med.(2005 Aug)
59.^Chicca A, Raduner S, Pellati F, Strompen T, Altmann KH, Schoop R, Gertsch JSynergistic immunomopharmacological effects of N-alkylamides in Echinacea purpurea herbal extractsInt Immunopharmacol.(2009 Jul)
60.^Raduner S, Majewska A, Chen JZ, Xie XQ, Hamon J, Faller B, Altmann KH, Gertsch JAlkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effectsJ Biol Chem.(2006 May 19)
61.^Woelkart K, Bauer RThe role of alkamides as an active principle of echinaceaPlanta Med.(2007 Jun)
62.^Haller J, Bakos N, Szirmay M, Ledent C, Freund TFThe effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxietyEur J Neurosci.(2002 Oct)
63.^Gertsch JImmunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid systemPlanta Med.(2008 May)
64.^Piomelli D, Tarzia G, Duranti A, Tontini A, Mor M, Compton TR, Dasse O, Monaghan EP, Parrott JA, Putman DPharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597)CNS Drug Rev.(2006 Spring)
65.^Haller J, Freund TF, Pelczer KG, Füredi J, Krecsak L, Zámbori JThe anxiolytic potential and psychotropic side effects of an echinacea preparation in laboratory animals and healthy volunteersPhytother Res.(2013 Jan)
66.^Shah SA, Schlesselman L, Cios D, Lipeika J, Patel AA, Kluger J, White CMEffects of echinacea on electrocardiographic and blood pressure measurementsAm J Health Syst Pharm.(2007 Aug 1)
67.^Pertwee RGThe pharmacology of cannabinoid receptors and their ligands: an overviewInt J Obes (Lond).(2006 Apr)
68.^Goel V, Chang C, Slama JV, Barton R, Bauer R, Gahler R, Basu TKAlkylamides of Echinacea purpurea stimulate alveolar macrophage function in normal ratsInt Immunopharmacol.(2002 Feb)
69.^Sullivan AM, Laba JG, Moore JA, Lee TDEchinacea-induced macrophage activationImmunopharmacol Immunotoxicol.(2008)
70.^Stevenson LM, Matthias A, Banbury L, Penman KG, Bone KM, Leach DL, Lehmann RPModulation of macrophage immune responses by EchinaceaMolecules.(2005 Oct 31)
71.^Tamta H, Pugh ND, Balachandran P, Moraes R, Sumiyanto J, Pasco DSVariability in in vitro macrophage activation by commercially diverse bulk echinacea plant material is predominantly due to bacterial lipoproteins and lipopolysaccharidesJ Agric Food Chem.(2008 Nov 26)
72.^Rossol M, Heine H, Meusch U, Quandt D, Klein C, Sweet MJ, Hauschildt SLPS-induced cytokine production in human monocytes and macrophagesCrit Rev Immunol.(2011)
73.^Senchina DS, Strauch JH, Hoffmann GB, Shah NB, Laflen BK, Dumke BL, Dao CT, Dias AS, Perera MAPhytochemical and immunomodulatory properties of an Echinacea laevigata (Asteraceae) tinctureJ Altern Complement Med.(2011 Apr)
74.^Kapai NA, Anisimova NY, Kiselevskii MV, Sitdikova SM, Slavetskaya MBSelective cytokine-inducing effects of low dose EchinaceaBull Exp Biol Med.(2011 Apr)
75.^Skopińska-Rózewska E, Sokolnicka I, Siwicki AK, Stankiewicz W, Dabrowski MP, Buchwald W, Krajewska-Patan A, Mielcarek S, Mścisz A, Furmanowa MDose-dependent in vivo effect of Rhodiola and Echinacea on the mitogen-induced lymphocyte proliferation in micePol J Vet Sci.(2011)
76.^Zhai Z, Liu Y, Wu L, Senchina DS, Wurtele ES, Murphy PA, Kohut ML, Cunnick JEEnhancement of innate and adaptive immune functions by multiple Echinacea speciesJ Med Food.(2007 Sep)
77.^Sasagawa M, Cech NB, Gray DE, Elmer GW, Wenner CAEchinacea alkylamides inhibit interleukin-2 production by Jurkat T cellsInt Immunopharmacol.(2006 Jul)
78.^Mishima S, Saito K, Maruyama H, Inoue M, Yamashita T, Ishida T, Gu YAntioxidant and immuno-enhancing effects of Echinacea purpureaBiol Pharm Bull.(2004 Jul)
79.^Morazzoni P, Cristoni A, Di Pierro F, Avanzini C, Ravarino D, Stornello S, Zucca M, Musso TIn vitro and in vivo immune stimulating effects of a new standardized Echinacea angustifolia root extract (Polinacea)Fitoterapia.(2005 Jul)
80.^Schwarz E, Parlesak A, Henneicke-von Zepelin HH, Bode JC, Bode CEffect of oral administration of freshly pressed juice of Echinacea purpurea on the number of various subpopulations of B- and T-lymphocytes in healthy volunteers: results of a double-blind, placebo-controlled cross-over studyPhytomedicine.(2005 Sep)
81.^Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka KImmunobiology of dendritic cellsAnnu Rev Immunol.(2000)
82.^Wang CY, Chiao MT, Yen PJ, Huang WC, Hou CC, Chien SC, Yeh KC, Yang WC, Shyur LF, Yang NSModulatory effects of Echinacea purpurea extracts on human dendritic cells: a cell- and gene-based studyGenomics.(2006 Dec)
83.^Wang CY, Staniforth V, Chiao MT, Hou CC, Wu HM, Yeh KC, Chen CH, Hwang PI, Wen TN, Shyur LF, Yang NSGenomics and proteomics of immune modulatory effects of a butanol fraction of echinacea purpurea in human dendritic cellsBMC Genomics.(2008 Oct 13)
84.^Dong GC, Chuang PH, Chang KC, Jan PS, Hwang PI, Wu HB, Yi M, Zhou HX, Chen HMBlocking effect of an immuno-suppressive agent, cynarin, on CD28 of T-cell receptorPharm Res.(2009 Feb)
85.^Yin SY, Wang WH, Wang BX, Aravindaram K, Hwang PI, Wu HM, Yang NSStimulatory effect of Echinacea purpurea extract on the trafficking activity of mouse dendritic cells: revealed by genomic and proteomic analysesBMC Genomics.(2010 Nov 1)
86.^Yu D, Yuan Y, Jiang L, Tai Y, Yang X, Hu F, Xie ZAnti-inflammatory effects of essential oil in Echinacea purpurea LPak J Pharm Sci.(2013 Mar)
87.^Rehman J, Dillow JM, Carter SM, Chou J, Le B, Maisel ASIncreased production of antigen-specific immunoglobulins G and M following in vivo treatment with the medicinal plants Echinacea angustifolia and Hydrastis canadensisImmunol Lett.(1999 Jun 1)
88.^Woelkart K, Linde K, Bauer REchinacea for preventing and treating the common coldPlanta Med.(2008 May)
89.^Schoop R, Klein P, Suter A, Johnston SLEchinacea in the prevention of induced rhinovirus colds: a meta-analysisClin Ther.(2006 Feb)
90.^Linde K, Barrett B, Wölkart K, Bauer R, Melchart DEchinacea for preventing and treating the common coldCochrane Database Syst Rev.(2006 Jan 25)
91.^Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJAssessing the quality of reports of randomized clinical trials: is blinding necessaryControl Clin Trials.(1996 Feb)
92.^Taylor JA, Weber W, Standish L, Quinn H, Goesling J, McGann M, Calabrese CEfficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trialJAMA.(2003 Dec 3)
93.^Sperber SJ, Shah LP, Gilbert RD, Ritchey TW, Monto ASEchinacea purpurea for prevention of experimental rhinovirus coldsClin Infect Dis.(2004 May 15)
94.^Turner RB, Bauer R, Woelkart K, Hulsey TC, Gangemi JDAn evaluation of Echinacea angustifolia in experimental rhinovirus infectionsN Engl J Med.(2005 Jul 28)
96.^Grimm W, Müller HHA randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of colds and respiratory infectionsAm J Med.(1999 Feb)
97.^Jawad M, Schoop R, Suter A, Klein P, Eccles RSafety and Efficacy Profile of Echinacea purpurea to Prevent Common Cold Episodes: A Randomized, Double-Blind, Placebo-Controlled TrialEvid Based Complement Alternat Med.(2012)
98.^Schulten B, Bulitta M, Ballering-Brühl B, Köster U, Schäfer MEfficacy of Echinacea purpurea in patients with a common cold. A placebo-controlled, randomised, double-blind clinical trialArzneimittelforschung.(2001)
99.^Cohen HA, Varsano I, Kahan E, Sarrell EM, Uziel YEffectiveness of an herbal preparation containing echinacea, propolis, and vitamin C in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled, multicenter studyArch Pediatr Adolesc Med.(2004 Mar)
100.^Barrett BP, Brown RL, Locken K, Maberry R, Bobula JA, D'Alessio DTreatment of the common cold with unrefined echinacea. A randomized, double-blind, placebo-controlled trialAnn Intern Med.(2002 Dec 17)
101.^Lindenmuth GF, Lindenmuth EBThe efficacy of echinacea compound herbal tea preparation on the severity and duration of upper respiratory and flu symptoms: a randomized, double-blind placebo-controlled studyJ Altern Complement Med.(2000 Aug)
102.^Petróczi A, Naughton DP, Mazanov J, Holloway A, Bingham JLimited agreement exists between rationale and practice in athletes' supplement use for maintenance of health: a retrospective studyNutr J.(2007 Oct 30)
103.^Gleeson M, Lancaster GI, Bishop NCNutritional strategies to minimise exercise-induced immunosuppression in athletesCan J Appl Physiol.(2001)
104.^Gleeson M, Nieman DC, Pedersen BKExercise, nutrition and immune functionJ Sports Sci.(2004 Jan)
105.^Schoop R, Büechi S, Suter AOpen, multicenter study to evaluate the tolerability and efficacy of Echinaforce Forte tablets in athletesAdv Ther.(2006 Sep-Oct)
106.^Hall H, Fahlman MM, Engels HJEchinacea purpurea and mucosal immunityInt J Sports Med.(2007 Sep)
107.^O'Neill W, McKee S, Clarke AFImmunological and haematinic consequences of feeding a standardised Echinacea (Echinacea angustifolia) extract to healthy horsesEquine Vet J.(2002 May)
108.^Whitehead MT, Martin TD, Scheett TP, Webster MJRunning economy and maximal oxygen consumption after 4 weeks of oral Echinacea supplementationJ Strength Cond Res.(2012 Jul)
109.^Whitehead MT, Martin TD, Scheett TP, Webster MJThe effect of 4 wk of oral echinacea supplementation on serum erythropoietin and indices of erythropoietic statusInt J Sport Nutr Exerc Metab.(2007 Aug)
110.^Szołomicki J, Samochowiec L, Wójcicki J, Droździk MThe influence of active components of Eleutherococcus senticosus on cellular defence and physical fitness in manPhytother Res.(2000 Feb)
111.^Di Carlo G, Pacilio M, Capasso R, Di Carlo REffect on prolactin secretion of Echinacea purpurea, hypericum perforatum and Eleutherococcus senticosusPhytomedicine.(2005 Sep)
112.^Dragland S, Senoo H, Wake K, Holte K, Blomhoff RSeveral culinary and medicinal herbs are important sources of dietary antioxidantsJ Nutr.(2003 May)
113.^Free-radical scavenging capacity and antioxidant activity of selected plant species from the Canadian prairies.()
117.^Antioxidant activity of cichoric acid and alkamides from Echinacea purpurea, alone and in combination.()
118.^Sharma M, Schoop R, Hudson JBThe efficacy of Echinacea in a 3-D tissue model of human airway epitheliumPhytother Res.(2010 Jun)
119.^Goel V, Chang C, Slama J, Barton R, Bauer R, Gahler R, Basu TEchinacea stimulates macrophage function in the lung and spleen of normal ratsJ Nutr Biochem.(2002 Aug)
120.^Fusco D, Liu X, Savage C, Taur Y, Xiao W, Kennelly E, Yuan J, Cassileth B, Salvatore M, Papanicolaou GAEchinacea purpurea aerial extract alters course of influenza infection in miceVaccine.(2010 May 21)
121.^Bodinet C, Mentel R, Wegner U, Lindequist U, Teuscher E, Freudenstein JEffect of oral application of an immunomodulating plant extract on Influenza virus type A infection in micePlanta Med.(2002 Oct)
122.^Uluışık D, Keskin EEffects of ginseng and echinacea on cytokine mRNA expression in ratsScientificWorldJournal.(2012)
123.^Yamada K, Hung P, Park TK, Park PJ, Lim BOA comparison of the immunostimulatory effects of the medicinal herbs Echinacea, Ashwagandha and BrahmiJ Ethnopharmacol.(2011 Sep 1)
124.^Spasov AA, Ostrovskij OV, Chernikov MV, Wikman GComparative controlled study of Andrographis paniculata fixed combination, Kan Jang and an Echinacea preparation as adjuvant, in the treatment of uncomplicated respiratory disease in childrenPhytother Res.(2004 Jan)
125.^Posadzki P, Watson LK, Ernst EAdverse effects of herbal medicines: an overview of systematic reviewsClin Med.(2013 Feb)
126.^Huntley AL, Thompson Coon J, Ernst EThe safety of herbal medicinal products derived from Echinacea species: a systematic reviewDrug Saf.(2005)
127.^Askeroglu U, Alleyne B, Guyuron BPharmaceutical and herbal products that may contribute to dry eyesPlast Reconstr Surg.(2013 Jan)
130.^Mullins RJ, Heddle RAdverse reactions associated with echinacea: the Australian experienceAnn Allergy Asthma Immunol.(2002 Jan)
131.^Cohen HA, Varsano I, Kahan E, Sarrell EM, Uziel YEffectiveness of an herbal preparation containing echinacea, propolis, and vitamin C in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled, multicenter studyArch Pediatr Adolesc Med.(2004 Mar)
132.^Lindenmuth GF, Lindenmuth EBThe efficacy of echinacea compound herbal tea preparation on the severity and duration of upper respiratory and flu symptoms: a randomized, double-blind placebo-controlled studyJ Altern Complement Med.(2000 Aug)
133.^Yakoot M, Salem AEfficacy and safety of a multiherbal formula with vitamin C and zinc (Immumax) in the management of the common coldInt J Gen Med.(2011 Jan 12)
134.^Naser B, Lund B, Henneicke-von Zepelin HH, Köhler G, Lehmacher W, Scaglione FA randomized, double-blind, placebo-controlled, clinical dose-response trial of an extract of Baptisia, Echinacea and Thuja for the treatment of patients with common coldPhytomedicine.(2005 Nov)
135.^Barth A, Hovhannisyan A, Jamalyan K, Narimanyan MAntitussive effect of a fixed combination of Justicia adhatoda, Echinacea purpurea and Eleutherococcus senticosus extracts in patients with acute upper respiratory tract infection: A comparative, randomized, double-blind, placebo-controlled studyPhytomedicine.(2015 Dec 1)
136.^ Thom E, Wollan TA controlled clinical study of Kanjang mixture in the treatment of uncomplicated upper respiratory tract infectionsPhyto Res.(1998 Dec)
137.^ Rahmati M, et alEfficacy and safety of echinacea root extracts in the treatment of pediatric common cold: A randomised clinical trialJ of Maz U Med Sci.(2012 Aug)
Primary Use